Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,473 | 700 | 62.2% |
| Consulting Fee | $5,770 | 2 | 23.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 1 | 6.0% |
| Travel and Lodging | $1,098 | 5 | 4.4% |
| Gift | $826.14 | 1 | 3.3% |
| Education | $216.74 | 17 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $4,936 | 8 | $0 (2023) |
| NxThera, Inc. | $2,354 | 4 | $0 (2018) |
| Boston Scientific Corporation | $1,707 | 24 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $1,457 | 85 | $0 (2024) |
| HISTOSONICS, INC. | $1,050 | 2 | $0 (2024) |
| PFIZER INC. | $994.62 | 50 | $0 (2024) |
| Astellas Pharma US Inc | $938.51 | 55 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $895.89 | 8 | $0 (2024) |
| Teleflex LLC | $743.71 | 13 | $0 (2024) |
| Antares Pharma, Inc. | $698.75 | 68 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,578 | 118 | Boston Scientific Corporation ($1,159) |
| 2023 | $3,015 | 124 | Myriad Genetic Laboratories, Inc. ($360.05) |
| 2022 | $2,970 | 114 | Teleflex LLC ($617.66) |
| 2021 | $6,251 | 82 | Alnylam Pharmaceuticals Inc. ($4,825) |
| 2020 | $1,016 | 49 | Dendreon Pharmaceuticals LLC ($155.14) |
| 2019 | $1,735 | 93 | Astellas Pharma US Inc ($251.19) |
| 2018 | $2,785 | 73 | NxThera, Inc. ($1,500) |
| 2017 | $2,534 | 73 | NxThera, Inc. ($853.74) |
All Payment Transactions
726 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/13/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $118.32 | General |
| Category: AMS 700_URO | ||||||
| 12/12/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $38.62 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/11/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: Continence Care | ||||||
| 12/11/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/11/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $0.75 | General |
| Category: Continence Care | ||||||
| 12/07/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/05/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $88.38 | General |
| Category: Urology | ||||||
| 12/03/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $21.01 | General |
| 11/26/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $86.94 | General |
| Category: HORMONE THERAPY | ||||||
| 11/15/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: AMS 700_URO | ||||||
| 11/15/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/06/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $17.39 | General |
| 11/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Diagnostic Imaging | ||||||
| 10/29/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $13.82 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,267 | 2,555 | $703,690 | $163,649 |
| 2022 | 30 | 2,305 | 2,956 | $795,083 | $222,154 |
| 2021 | 31 | 2,111 | 4,856 | $894,569 | $248,900 |
| 2020 | 28 | 1,971 | 2,669 | $529,451 | $188,516 |
All Medicare Procedures & Services
120 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 413 | 508 | $130,048 | $43,308 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 294 | 331 | $59,580 | $19,669 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 169 | 169 | $55,939 | $19,432 | 34.7% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 46 | 46 | $42,274 | $12,255 | 29.0% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 21 | 21 | $38,913 | $9,141 | 23.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 124 | 138 | $79,902 | $8,312 | 10.4% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 14 | 15 | $25,740 | $5,197 | 20.2% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 101 | 109 | $15,805 | $4,610 | 29.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 60 | 60 | $13,260 | $4,227 | 31.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 24 | 24 | $13,896 | $3,979 | 28.6% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 45 | 45 | $12,465 | $3,628 | 29.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 24 | $9,432 | $3,215 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 34 | 35 | $8,960 | $2,631 | 29.4% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 34 | 34 | $21,046 | $2,517 | 12.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $6,141 | $2,310 | 37.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 240 | 297 | $10,989 | $2,279 | 20.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 38 | $5,358 | $2,260 | 42.2% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 34 | 45 | $6,750 | $2,118 | 31.4% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 15 | 18 | $23,016 | $2,019 | 8.8% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2023 | 11 | 12 | $32,856 | $1,773 | 5.4% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 11 | 11 | $5,390 | $1,633 | 30.3% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Facility | 2023 | 14 | 14 | $10,808 | $1,554 | 14.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 60 | 60 | $20,520 | $1,315 | 6.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 24 | 24 | $4,320 | $1,221 | 28.3% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 17 | 18 | $31,594 | $1,049 | 3.3% |
About Dr. Matthew Steinway, M.D
Dr. Matthew Steinway, M.D is a Urology healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346454246.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Steinway, M.D has received a total of $24,884 in payments from pharmaceutical and medical device companies, with $4,578 received in 2024. These payments were reported across 726 transactions from 76 companies. The most common payment nature is "Food and Beverage" ($15,473).
As a Medicare-enrolled provider, Steinway has provided services to 8,654 Medicare beneficiaries, totaling 13,036 services with total Medicare billing of $823,220. Data is available for 4 years (2020–2023), covering 120 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Scottsdale, AZ
- Active Since 05/09/2007
- Last Updated 03/21/2025
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1346454246
Products in Payments
- OXLUMO (Drug) $4,848
- Rezum (Device) $2,354
- PROVENGE (Drug) $1,522
- XTANDI (Drug) $1,408
- Rezum Generator (Device) $1,021
- Da Vinci Surgical System (Device) $895.89
- UROLIFT (Device) $527.76
- AQUABEAM ROBOTIC SYSTEM (Device) $520.20
- XIAFLEX (Biological) $483.88
- XARELTO (Drug) $454.46
- PYLARIFY (Drug) $376.79
- Axumin (Drug) $334.75
- XYOSTED (Drug) $302.80
- NOCDURNA (Drug) $279.37
- KEYTRUDA (Biological) $241.49
- ORGOVYX (Drug) $240.29
- CAMCEVI (Drug) $238.90
- Erleada (Drug) $235.28
- AVEED (Biological) $232.20
- PROLARIS (Device) $222.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Scottsdale
Suzette Sutherland, M.d, M.D
Urology — Payments: $276,266
Dr. Thayne Larson, Md, MD
Urology — Payments: $47,594
Lipika Mccauley, M.d, M.D
Urology — Payments: $44,314
Dr. Michael Zell, Md, MD
Urology — Payments: $40,943
Anojan Navaratnam, Mbbs, MBBS
Urology — Payments: $30,357
Mark Tyson, M.d, M.D
Urology — Payments: $20,645